Drug
GSK561679
GSK561679 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
4
80%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Analyzing Female Trauma Exposed Responses to a Medication
NCT01814332
completedphase_2
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
NCT00733980
completedphase_1
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
NCT00426608
completedphase_2
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
NCT01018992
completedphase_2
CRF1 Antagonist GSK561679 in Alcoholism
NCT01187511
Clinical Trials (5)
Showing 5 of 5 trials
NCT01814332Phase 2
Analyzing Female Trauma Exposed Responses to a Medication
NCT00733980Phase 2
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
NCT00426608Phase 1
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
NCT01018992Phase 2
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
NCT01187511Phase 2
CRF1 Antagonist GSK561679 in Alcoholism
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5